- Home
- SITM vs MRUS Comparison
SITM vs MRUS Comparison
Compare SITM & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SITM
- MRUS
- Stock Information
- Founded
- SITM 2003
- MRUS 2003
- Country
- SITM United States
- MRUS Netherlands
- Employees
- SITM N/A
- MRUS N/A
- Industry
- SITM Semiconductors
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- SITM Technology
- MRUS Health Care
- Exchange
- SITM Nasdaq
- MRUS Nasdaq
- Market Cap
- SITM 4.7B
- MRUS 4.1B
- IPO Year
- SITM 2019
- MRUS 2016
- Fundamental
- Price
- SITM $206.29
- MRUS $54.74
- Analyst Decision
- SITM Strong Buy
- MRUS Strong Buy
- Analyst Count
- SITM 5
- MRUS 13
- Target Price
- SITM $224.00
- MRUS $88.54
- AVG Volume (30 Days)
- SITM 438.5K
- MRUS 732.2K
- Earning Date
- SITM 08-06-2025
- MRUS 07-31-2025
- Dividend Yield
- SITM N/A
- MRUS N/A
- EPS Growth
- SITM N/A
- MRUS N/A
- EPS
- SITM N/A
- MRUS N/A
- Revenue
- SITM $229,989,000.00
- MRUS $54,732,000.00
- Revenue This Year
- SITM $38.12
- MRUS $75.57
- Revenue Next Year
- SITM $23.93
- MRUS $31.84
- P/E Ratio
- SITM N/A
- MRUS N/A
- Revenue Growth
- SITM 65.85
- MRUS 42.77
- 52 Week Low
- SITM $105.40
- MRUS $33.19
- 52 Week High
- SITM $268.18
- MRUS $62.98
- Technical
- Relative Strength Index (RSI)
- SITM 48.09
- MRUS 56.79
- Support Level
- SITM $201.88
- MRUS $51.78
- Resistance Level
- SITM $213.00
- MRUS $55.30
- Average True Range (ATR)
- SITM 9.68
- MRUS 1.63
- MACD
- SITM -2.20
- MRUS -0.11
- Stochastic Oscillator
- SITM 15.89
- MRUS 84.09
About SITM SiTime Corporation
SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.